Abstract
The treatment of laryngeal and hypopharyngel cancer nowadays is not limited by surgical resection. There are many interdisciplinary approaches which we can offer these patients in our clinics. These include radiotherapy, chemotherapy, biologicals and surgery. The combination of radiotherapy, chemotherapy, biologicals and surgery techniques more and more allows us to perform organ and function preservation in a former often mutilating and function destroying treatment. Since the early 1990s, evidence from large randomized trials has shown that organ preservation studies using sequential and concomitant radio-chemotherapy do not compromise survival when compared with surgery followed by radiotherapy. However, using these therapies side effects have to be taken into consideration and not organ preservation but function preservation is the treatment goal. The current most common treatment options are shown here in this review. For future treatment protocols there is an urgent need to refine the definition of a functional organ, to define quality of life endpoints and to refine the recommendations for evaluating treatment response.
Similar content being viewed by others
References
Jemal A, Siegel R, Ward E, Hao Y, Xu J, Thun MJ (2009) Cancer statistics, 2009. CA Cancer J Clin 59(4):225–249
Robert Koch-Institut GdeKiDeV (ed) (2010) Krebs in Deutschland 2005/2006—Häufigkeiten und Trends. 7 ed. Berlin: Robert Koch-Institut und die Gesellschaft der epidemiologischen Krebsregister in Deutschland e. V.
Holsinger FC (2008) Swing of the pendulum: optimizing functional outcomes in larynx cancer. Curr Oncol Rep 10(2):170–175
Lefebvre JL (1998) Larynx preservation: the discussion is not closed. Otolaryngol Head Neck Surg 118(3 Pt 1):389–393
Pignon JP, Bourhis J, Domenge C, Designe L (2000) Chemotherapy added to locoregional treatment for head and neck squamous-cell carcinoma: three meta-analyses of updated individual data. MACH-NC Collaborative Group. Meta-analysis of chemotherapy on head and neck cancer. Lancet 355(9208):949–955
Pignon JP, le Maitre A, Bourhis J (2007) Meta-analyses of chemotherapy in head and neck cancer (MACH-NC): an update. Int J Radiat Oncol Biol Phys 69(2 Suppl):S112–S114
Wolf GTHW, Gross Fisher S (1991) Induction chemotherapy plus radiation compared with surgery plus radiation in patients with advanced laryngeal cancer (The Department of Veterans Affairs [VA] Laryngeal Cancer Study Group). N Engl J Med 324:1685–1690
Forastiere AA, Goepfert H, Maor M, Pajak TF, Weber R, Morrison W et al (2003) Concurrent chemotherapy and radiotherapy for organ preservation in advanced laryngeal cancer. N Engl J Med 349(22):2091–2098
Olsen KD (2010) Reexamining the treatment of advanced laryngeal cancer. Head Neck 32(1):1–7
Lefebvre JL, Chevalier D, Luboinski B, Kirkpatrick A, Collette L, Sahmoud T (1996) Larynx preservation in pyriform sinus cancer: preliminary results of a European Organization for Research and Treatment of Cancer phase III trial. EORTC Head and Neck Cancer Cooperative Group. J Natl Cancer Inst 88(13):890–899
Richard JM, Sancho-Garnier H, Pessey JJ, Luboinski B, Lefebvre JL, Dehesdin D et al (1998) Randomized trial of induction chemotherapy in larynx carcinoma. Oral Oncol 34(3):224–228
Forastiere AA, Maor M, Weber RS, Pajak T, Glisson B, Trotti A et al. (2006) Long-term results of Intergroup RTOG 91-11: a phase III trial to preserve the larynx—induction cisplatin/5-FU and radiation therapy versus concurrent cisplatin and radiation therapy versus radiation therapy. ASCO Meeting Abstracts 24(18 Suppl):5517
Trotti A, Pajak TF, Gwede CK, Paulus R, Cooper J, Forastiere A et al (2007) TAME: development of a new method for summarising adverse events of cancer treatment by the Radiation Therapy Oncology Group. Lancet Oncol 8(7):613–624
Lefebvre JL, Rolland F, Tesselaar M, Bardet E, Leemans CR, Geoffrois L et al (2009) Phase 3 randomized trial on larynx preservation comparing sequential vs alternating chemotherapy and radiotherapy. J Natl Cancer Inst 101(3):142–152
Adelstein DJ, Rodriguez CP (2008) Current and emerging standards of concomitant chemoradiotherapy. Semin Oncol 35(3):211–220
Forastiere AA (2008) Chemotherapy in the treatment of locally advanced head and neck cancer. J Surg Oncol 97(8):701–707
Cmelak AJ, Li S, Goldwasser MA, Murphy B, Cannon M, Pinto H et al (2007) Phase II trial of chemoradiation for organ preservation in resectable stage III or IV squamous cell carcinomas of the larynx or oropharynx: results of Eastern Cooperative Oncology Group Study E2399. J Clin Oncol 25(25):3971–3977
Biete Sola A, Marruecos Querol J, Calvo Manuel FA, Verger Fransoy E, Rovirosa Casino A, Grau de Castro JJ et al (2007) Phase II trial: concurrent radio-chemotherapy with weekly docetaxel for advanced squamous cell carcinoma of head and neck. Clin Transl Oncol 9(4):244–250
Mantz CA, Vokes EE, Kies MS, Mittal B, Witt ME, List MA et al (2001) Sequential induction chemotherapy and concomitant chemoradiotherapy in the management of locoregionally advanced laryngeal cancer. Ann Oncol 12(3):343–347
Pointreau Y, Garaud P, Chapet S, Sire C, Tuchais C, Tortochaux J et al (2009) Randomized trial of induction chemotherapy with cisplatin and 5-fluorouracil with or without docetaxel for larynx preservation. J Natl Cancer Inst 101(7):498–506
Posner MR, Norris CM, Wirth LJ, Shin DM, Cullen KJ, Winquist EW et al (2009) Sequential therapy for the locally advanced larynx and hypopharynx cancer subgroup in TAX 324: survival, surgery, and organ preservation. Ann Oncol 20(5):921–927
Posner MR, Lorch JH, Goloubeva O, Tan M, Schumaker L, Sarlis NJ et al. (2010) Oropharynx cancer (OPC) in TAX 324: Human papillomavirus (HPV) and survival. ASCO Meeting Abstracts 28(15 Suppl):5525
Lorch JH, Posner MR, Goloubeva O, Cullen KJ, Sarlis NJ, Tishler RB et al. (2010) Long-term results from TAX324: a phase III trial of sequential therapy comparing TPF to PF in locally advanced (LA) squamous cell cancer of the head and neck (HNC). ASCO Meeting Abstracts 28(15 Suppl):5512
Vermorken JB, Remenar E, van Herpen C, Gorlia T, Mesia R, Degardin M et al (2007) Cisplatin, fluorouracil, and docetaxel in unresectable head and neck cancer. N Engl J Med 357(17):1695–1704
Goodwin WJ Jr (2000) Salvage surgery for patients with recurrent squamous cell carcinoma of the upper aerodigestive tract: when do the ends justify the means? Laryngoscope 110(3 Pt 2 Suppl 93):1–18
Pomerantz RG, Grandis JR (2004) The epidermal growth factor receptor signaling network in head and neck carcinogenesis and implications for targeted therapy. Semin Oncol 31(6):734–743
Bonner JA, Harari PM, Giralt J, Azarnia N, Shin DM, Cohen RB et al (2006) Radiotherapy plus cetuximab for squamous-cell carcinoma of the head and neck. N Engl J Med 354(6):567–578
Brumund KT, Gutierrez-Fonseca R, Garcia D, Babin E, Hans S, Laccourreye O (2005) Frontolateral vertical partial laryngectomy without tracheotomy for invasive squamous cell carcinoma of the true vocal cord: a 25-year experience. Ann Otol Rhinol Laryngol 114(4):314–322
Dufour X, Hans S, De Mones E, Brasnu D, Menard M, Laccourreye O (2004) Local control after supracricoid partial laryngectomy for “advanced” endolaryngeal squamous cell carcinoma classified as T3. Arch Otolaryngol Head Neck Surg 130(9):1092–1099
Tufano RP (2002) Organ preservation surgery for laryngeal cancer. Otolaryngol Clin North Am 35(5):1067–1080
Sheen TS, Ko JY, Chang YL (1998) Partial vertical laryngectomy in the treatment of early glottic cancer. Ann Otol Rhinol Laryngol 107(7):593–597
Yeager LB, Grillone GA (2005) Organ preservation surgery for intermediate size (T2 and T3) laryngeal cancer. Otolaryngol Clin North Am 38(1):11–20 vii
Wein RO, Weber RS (2005) The current role of vertical partial laryngectomy and open supraglottic laryngectomy. Curr Probl Cancer 29(4):201–214
Strong MS, Jako GJ (1972) Laser surgery in the larynx. Early clinical experience with continuous CO 2 laser. Ann Otol Rhinol Laryngol 81(6):791–798
Steiner W, Ambrosch P, Hess CF, Kron M (2001) Organ preservation by transoral laser microsurgery in piriform sinus carcinoma. Otolaryngol Head Neck Surg 124(1):58–67
Ambrosch P, Kron M, Steiner W (1998) Carbon dioxide laser microsurgery for early supraglottic carcinoma. Ann Otol Rhinol Laryngol 107(8):680–688
Steiner W, Fierek O, Ambrosch P, Hommerich CP, Kron M (2003) Transoral laser microsurgery for squamous cell carcinoma of the base of the tongue. Arch Otolaryngol Head Neck Surg 129(1):36–43
Ambrosch P (2007) The role of laser microsurgery in the treatment of laryngeal cancer. Curr Opin Otolaryngol Head Neck Surg 15(2):82–88
O’Malley BW Jr, Weinstein GS, Snyder W, Hockstein NG (2006) Transoral robotic surgery (TORS) for base of tongue neoplasms. Laryngoscope 116(8):1465–1472
Weinstein GS, O’Malley BW Jr, Snyder W, Sherman E, Quon H (2007) Transoral robotic surgery: radical tonsillectomy. Arch Otolaryngol Head Neck Surg 133(12):1220–1226
Weinstein GS, O’Malley BW Jr, Snyder W, Hockstein NG (2007) Transoral robotic surgery: supraglottic partial laryngectomy. Ann Otol Rhinol Laryngol 116(1):19–23
Silver CE, Beitler JJ, Shaha AR, Rinaldo A, Ferlito A (2009) Current trends in initial management of laryngeal cancer: the declining use of open surgery. Eur Arch Otorhinolaryngol 266(9):1333–1352
Cooper JS, Porter K, Mallin K, Hoffman HT, Weber RS, Ang KK et al (2009) National Cancer Database report on cancer of the head and neck: 10-year update. Head Neck 31(6):748–758
Chen AY, Schrag N, Hao Y, Stewart A, Ward E (2007) Changes in treatment of advanced oropharyngeal cancer, 1985–2001. Laryngoscope 117(1):16–21
Hoffman HT, Porter K, Karnell LH, Cooper JS, Weber RS, Langer CJ et al (2006) Laryngeal cancer in the United States: changes in demographics, patterns of care, and survival. Laryngoscope 116(9 Pt 2 Suppl 111):1–13
Chen AY, Halpern M (2007) Factors predictive of survival in advanced laryngeal cancer. Arch Otolaryngol Head Neck Surg 133(12):1270–1276
Bosetti C, Bertuccio P, Levi F, Lucchini F, Negri E, La Vecchia C (2008) Cancer mortality in the European Union, 1970–2003, with a joinpoint analysis. Ann Oncol 19(4):631–640
La Vecchia C, Bosetti C, Lucchini F, Bertuccio P, Negri E, Boyle P et al (2009) Cancer mortality in Europe, 2000–2004, and an overview of trends since 1975. Ann Oncol 21(6):1323–1360
Pfister DG, Laurie SA, Weinstein GS, Mendenhall WM, Adelstein DJ, Ang KK et al (2006) American Society of Clinical Oncology clinical practice guideline for the use of larynx-preservation strategies in the treatment of laryngeal cancer. J Clin Oncol 24(22):3693–3704
Beitler JJ, Cooper JS (2009) Seduction by induction? J Clin Oncol 27(1):9–10
Conflict of interest
The authors have no conflict of interest.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Wang, CJ., Knecht, R. Current concepts of organ preservation in head and neck cancer. Eur Arch Otorhinolaryngol 268, 481–487 (2011). https://doi.org/10.1007/s00405-010-1407-8
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00405-010-1407-8